RMDA
Cairo - Mubasher: Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) stated that LVP PHARMA raised its stake to 11.76% from 9.22%.
LVP PHARMA purchased 51.52 million shares at an average price of EGP 4.17 per share, according to a bourse filing.
Meanwhile, the total value of the transaction stood at EGP 215.30 million.
It is worth noting that Al Ahly Pharos for Securities Brokerage acted as the broker for this transaction.
In July 2025, the extraordinary general meeting (EGM) of Rameda greenlighted increasing its capital to EGP 500 million from EGP 377.74 million.